Tumor Mutational Burden by TSO500 Next Generation Sequencing Panel and Clinical Outcome in Non-Small Cell Lung Cancer

被引:1
|
作者
Cuppens, K. [1 ]
Froyen, G. [2 ]
Cruys, B. [2 ]
Geerdens, E. [2 ]
Achten, R. [3 ]
Vanbockrijck, M. [3 ]
Maes, B. [2 ]
机构
[1] Jessa Hosp, Pulmonol & Thorac Oncol, Hasselt, Belgium
[2] Jessa Hosp, Lab Mol Diagnost, Hasselt, Belgium
[3] Jessa Hosp, Pathol, Hasselt, Belgium
关键词
tumor mutational burden (TMB); Immunotherapy; Next generation sequencing;
D O I
10.1016/j.jtho.2019.08.1581
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2.04-76
引用
收藏
页码:S738 / S739
页数:2
相关论文
共 50 条
  • [31] META-ANALYSIS OF NEXT GENERATION SEQUENCING PANEL USING CIRCULATING TUMOR DNA IN PATIENT WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Ho, R.
    Sebastiao, M.
    Carvalho, J.
    Bramley, S.
    Schneider, C.
    Nussbaum, M.
    [J]. VALUE IN HEALTH, 2020, 23 : S250 - S250
  • [32] Mutation profile of non-small cell lung cancer revealed by next generation sequencing
    Chang, Ya-Sian
    Tu, Siang-Jyun
    Chen, Yu-Chia
    Liu, Ting-Yuan
    Lee, Ya-Ting
    Yen, Ju-Chen
    Fang, Hsin-Yuan
    Chang, Jan-Gowth
    [J]. RESPIRATORY RESEARCH, 2021, 22 (01)
  • [33] Changes in tumor mutational burden in serially biopsied non-small cell lung cancer.
    Smithy, James W.
    Hwang, David H.
    Li, Yvonne Y.
    Spurr, Liam
    Cherniack, Andrew D.
    Sholl, Lynette M.
    Awad, Mark M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [34] Targeted next-generation sequencing to assess tumor mutation burden: ready for prime-time in non-small cell lung cancer?
    Tomasini, Pascale
    Greillier, Laurent
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S323 - S326
  • [35] Prospective mutational characterization of Japanese patients with non-small cell lung cancer using surgically resected tumor specimens by next-generation sequencing
    Koh, Y.
    Kenmotsu, H.
    Serizawa, M.
    Isaka, M.
    Mori, K.
    Takahashi, T.
    Endo, M.
    Nakajima, T.
    Ohde, Y.
    Yamamoto, N.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S12 - S12
  • [36] Plasma CfDNA next Generation Sequencing in Non-Small Cell Lung Cancer: Clinical Outcomes and Comparison to Tissue
    Raez, L.
    Mekhail, T.
    Rodriguez, E.
    Hunis, B.
    Nashed, A.
    Dietrich, M.
    Nagy, R.
    Kiedrowski, L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1862 - S1862
  • [37] Routine Clinical Mutation Profiling of Non-Small Cell Lung Cancer Using Next-Generation Sequencing
    Deeb, Kristin K.
    Hohman, Colleen M.
    Risch, Nicholas F.
    Metzger, Daniel J.
    Starostik, Petr
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (07) : 913 - 921
  • [38] Paired analysis of tumor mutation burden calculated by targeted deep sequencing panel and whole exome sequencing in non-small cell lung cancer
    Park, Sehhoon
    Lee, Chung
    Ku, Bo Mi
    Kim, Minjae
    Park, Woong-Yang
    Kim, Nayoung K. D.
    Ahn, Myung-Ju
    [J]. BMB REPORTS, 2021, 54 (07) : 386 - 391
  • [39] Association of tumor mutational burden with smoking and mutation status in non-small cell lung cancer (NSCLC).
    Davis, Andrew A.
    Chae, Young Kwang
    Agte, Sarita
    Pan, Alan
    Mohindra, Nisha Anjali
    Villaflor, Victoria Meucci
    Giles, Francis J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [40] Tumor mutational burden in non-small cell lung cancer-the pathologist's point of view
    Penault-Llorca, Frederique
    Radosevic-Robin, Nina
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (06) : 716 - 721